Search research articles
Contact Us
Filters
Showing results (151-160 of 178) with videos related to
Page
of 18
Sort By:
International Journal of Oncology
|
December 21, 2012
Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis
Masato Komatsu, Tetsuro Yoshimaru, Taisuke Matsuo, et al.
Journal of Cancer Research and Clinical Oncology
|
October 17, 2007
Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancers
Yasuo Miyoshi, Masafumi Kurosumi, Junichi Kurebayashi, et al.
Cancer Letters
|
February 19, 2008
Topoisomerase IIalpha-positive and BRCA1-negative phenotype: association with favorable response to epirubicin-based regimens for human breast cancers
Yasuo Miyoshi, Masafumi Kurosumi, Junichi Kurebayashi, et al.
The Breast Journal
|
November 13, 2008
Potential of reduction in total tumor volume measured with 3D-MRI as a prognostic factor for locally-advanced breast cancer patients treated with primary chemotherapy
Kenji Akazawa, Yasuhiro Tamaki, Tetsuya Taguchi, et al.
International Journal of Oncology
|
June 10, 2016
Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy
Jae-Hyun Park, Miran Jang, Yunus Emre Tarhan, et al.
World Journal of Surgical Oncology
|
February 14, 2018
Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes
Michiko Imamura, Takashi Morimoto, Takashi Nomura, et al.
Breast Cancer Research and Treatment
|
May 23, 2019
Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study
Shinji Ohno, Hirofumi Mukai, Kazutaka Narui, et al.
Breast Cancer (Tokyo, Japan)
|
September 4, 2013
Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women
Yoshimasa Miyagawa, Tomohiro Miyake, Ayako Yanai, et al.
Anticancer Research
|
July 2, 2014
Phase II study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancer
Tsutomu Takashima, Takahiro Nakayama, Katsuhide Yoshidome, et al.
Nature Communications
|
September 21, 2013
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells
Tetsuro Yoshimaru, Masato Komatsu, Taisuke Matsuo, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 178) with videos related to
Sort By:
Page
of 18
International Journal of Oncology
|
December 21, 2012
Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis
Masato Komatsu, Tetsuro Yoshimaru, Taisuke Matsuo, et al.
Journal of Cancer Research and Clinical Oncology
|
October 17, 2007
Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancers
Yasuo Miyoshi, Masafumi Kurosumi, Junichi Kurebayashi, et al.
Cancer Letters
|
February 19, 2008
Topoisomerase IIalpha-positive and BRCA1-negative phenotype: association with favorable response to epirubicin-based regimens for human breast cancers
Yasuo Miyoshi, Masafumi Kurosumi, Junichi Kurebayashi, et al.
The Breast Journal
|
November 13, 2008
Potential of reduction in total tumor volume measured with 3D-MRI as a prognostic factor for locally-advanced breast cancer patients treated with primary chemotherapy
Kenji Akazawa, Yasuhiro Tamaki, Tetsuya Taguchi, et al.
International Journal of Oncology
|
June 10, 2016
Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy
Jae-Hyun Park, Miran Jang, Yunus Emre Tarhan, et al.
World Journal of Surgical Oncology
|
February 14, 2018
Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes
Michiko Imamura, Takashi Morimoto, Takashi Nomura, et al.
Breast Cancer Research and Treatment
|
May 23, 2019
Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study
Shinji Ohno, Hirofumi Mukai, Kazutaka Narui, et al.
Breast Cancer (Tokyo, Japan)
|
September 4, 2013
Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women
Yoshimasa Miyagawa, Tomohiro Miyake, Ayako Yanai, et al.
Anticancer Research
|
July 2, 2014
Phase II study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancer
Tsutomu Takashima, Takahiro Nakayama, Katsuhide Yoshidome, et al.
Nature Communications
|
September 21, 2013
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells
Tetsuro Yoshimaru, Masato Komatsu, Taisuke Matsuo, et al.
Page
of 18